@Unplugged_03 @peterinSilico @pitzwang I accept there is a big problem with virology. Lack of proofs, absence of control experiments ans so on. But I do think there was a novel presentation of disease in earkly spring 2020. https://t.co/ptwz493cTc
RT @qrPovpz8L33YIcW: @ascensiontvjp コロナ肺炎の病態は複雑なようですね。 Covid-19 pneumoniaでやると、イロンナ画像ご出てきました😨😱🤔 https://t.co/udgnhgyUgb
@ascensiontvjp コロナ肺炎の病態は複雑なようですね。 Covid-19 pneumoniaでやると、イロンナ画像ご出てきました😨😱🤔 https://t.co/udgnhgyUgb
@load_dependent @pseudo_sapiens @deralteGaukler @GermHunterMD @LancetRespirMed @progdoctalk @JAMANetwork @radboudumc @gattinon Prof Gattinoni claims that it is: C 'COVID-19 pneumonia: ARDS or not?' https://t.co/Yiy3WJ0Zfh I agree with you Lars that these a
Is COVID19 pneumonia: ARDS or not? In Italy, only 20-30% of critically ill #COVID19 pneumonia patients had ARDS (Low compliance, type 2), rest had a ventilation-perfusion mismatch due to impaired pulmonary blood flow most likely from lung clots (type 1) =&
RT @drdiegocosta: @EzequielZaidel Hay mucha discusión sobre el tema de ventilación en COVID-19. Me gustó mucho el artículo de Gattinoni: ht…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al 2 types of #COVID19 patients are distinguishable: non-ARDS (type1), &…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al 2 types of #COVID19 patients are distinguishable: non-ARDS (type1), &…
RT @FatmaMag: references : https://t.co/Q3dZmLGESm https://t.co/BPiVCjAelf https://t.co/axcL9aElXY
RT @BebetoDice: @OrlandoRPN @Smester07 Gattinoni los dividió en dos grupos https://t.co/J3yo6BL1Lv
@lissasauras @RoundRockTim This is more to my point https://t.co/0XenzqIPfG
@SwiftRead Those metrics are not stand-alone. They overlap. Apart from the math, the ICD-10 code definitions tell you that those two categories overlap. The ICODs for most covid19 deaths are ARDS/hypoxemia. For some others it is pneumonia, viral or second
RT @nurse4change: ARDS considered rare,(>200,000 ,but it seemed pretty frequent in our busy ICU), the seriously ill #SARSCoV2 patients als…
ARDS considered rare,(>200,000 ,but it seemed pretty frequent in our busy ICU), the seriously ill #SARSCoV2 patients also can have this very challenging clinical manifestation as if just #Covid19 is not challenging enough for some. #StaySafeStayHome
RT @doctor_finesse: COVID-19 pneumonia: ARDS or not? | Critical Care | Full Text https://t.co/PPdYyjvYYm
COVID-19 pneumonia: ARDS or not? | Critical Care | Full Text https://t.co/PPdYyjvYYm
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al 2 types of #COVID19 patients are distinguishable: non-ARDS (type1), &…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @pharmaciensAPES: 2 types de patients COVID selon la présentation clinique? https://t.co/PGUbgSVh2i https://t.co/WsXOjmsnWU
2 types de patients COVID selon la présentation clinique? https://t.co/PGUbgSVh2i https://t.co/WsXOjmsnWU
RT @flohin: COVID-19 pneumonia: ARDS or not? | Critical Care | Full Text @DrGomi @T_Nenninger https://t.co/2RAoMemimX
RT @flohin: COVID-19 pneumonia: ARDS or not? | Critical Care | Full Text @DrGomi @T_Nenninger https://t.co/2RAoMemimX
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al 2 types of #COVID19 patients are distinguishable: non-ARDS (type1), &…
@_mingleigh Covid19 causes pneumonia. That's worth mentioning too. https://t.co/5AugrzCLaw
@MuschiLambi @DianaEspir @RocksRoxana @TomiLahren @tekwendell @BasedPoland There is a new clinical trial that will take place in japan using Ibudilast, so this should be considered along with it https://t.co/6iYAgqs5ww
@iwashyna @KaminskiMed Well not so fast. Apparently Prof Gattinoni (who has much more experience than I) summarized the Italian #Covid19 experience into 2 phenotypes: The hypoxic normal compliance #NotYourFathersARDS which is 70 % and a low compliance s
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @renalpages: 2 types of lung involvement in COVID19 pneumonia Type 1 Near normal pulmonary compliance with isolated viral pneumonia t…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
@EzequielZaidel Hay mucha discusión sobre el tema de ventilación en COVID-19. Me gustó mucho el artículo de Gattinoni: https://t.co/JdPoUqUFjf
2 types of lung involvement in COVID19 pneumonia Type 1 Near normal pulmonary compliance with isolated viral pneumonia type 2 -Decreased pulmonary compliance https://t.co/4f1tIuyX1X Prone ventilation sometimes helpful Fluid balance not easy – even in
@robblakeslee @Qynton @gatewaypundit You're very welcome. You may also find this article interesting. I certainly did Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumonia: ARDS or not? | Critical C
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
@KerrPuter @mgyory @ewarren Covid19 is the reason the percentage of deaths due to pneumonia is spiking. Covid19 pneumonia is killing a lot of people. https://t.co/5AugrzCLaw
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al 2 types of #COVID19 patients are distinguishable: non-ARDS (type1), &…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
tiens, enfin des mecs qui réfléchissent: https://t.co/AYpilNMb5E
RT @richardursomd: Late treatment still a big unknown. Treat early!! COVID-19 pneumonia: ARDS or not? | Critical Care | Full Text https://t…
ARDSを伴うCOVID-19患者の管理 重症ARDS患者に対して行う普通の治療を行う ・低一回換気量 ・腹臥位療法 ・比較的高めのPEEP) 重症低酸素でも腹臥位がどの症例にも効果的であるわけではないということでした。 https://t.co/kOctFvBaHd
ARDSを伴わないCOVID-19患者の管理 ・肺コンプライアンスが良好な患者ではPEEPは低めで! ・1回換気量は6ml/kgに制限しなくて良い ・呼吸回数は20を超えるべきではない ・患者は安静にさせるのがどんな高コストの介入よりも良い https://t.co/kOctFvBaHd
COVID-19 pneumonia: ARDS or not? | Critical Care | Full Text https://t.co/8IdJTpSs17
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @Infermiere_line: COVID-19 pneumonia: #ARDS or not? @Crit_Care | #ECM https://t.co/7AeOwVZDL4
COVID-19 pneumonia: #ARDS or not? @Crit_Care | #ECM https://t.co/7AeOwVZDL4
COVID-19 pneumonia: #ARDS or not? @Crit_Care | #ECM https://t.co/OEivtAvAXy
COVID-19 pneumonia: ARDS or not? | Critical Care | Full Text https://t.co/8IdJTpSs17
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al 2 types of #COVID19 patients are distinguishable: non-ARDS (type1), &…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @curso_vm: Nobody listened to me when I said that the L phenotype was not ARDS ... @MonaresTI
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al 2 types of #COVID19 patients are distinguishable: non-ARDS (type1), &…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al 2 types of #COVID19 patients are distinguishable: non-ARDS (type1), &…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
#CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1), & #ARDS (type2) with different pathophysiology & clinical implications #FOAMed #FOAMcc #ICU #IntensiveCare #pneumonia #PEEP
COVID-19 pneumonia: ARDS or not? Type 1: Near normal pulmonary compliance with isolated viral pneumonia Type 2: Decreased pulmonary compliance https://t.co/Dmt1GSOJp1 https://t.co/oDptPSQx2f
RT @DrSenthi: Newly published article by Gattinoni; COVID-19: ARDS or not? Provides further discussion on the phenotypical distinctions a…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al 2 types of #COVID19 patients are distinguishable: non-ARDS (type1), &…
@Cara_TXZEAL @moneypenny_2020 @turnbolt11 @RMachArts @g_easton819 Article worth the read https://t.co/0Vm85ivMQO
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al 2 types of #COVID19 patients are distinguishable: non-ARDS (type1), &…